Name: PubCaseFinder
License: http://creativecommons.org/licenses/by/2.1/jp/
Keywords: PubCaseFinder,PCF,Rare Disease,Phenotype,Gene,Match,Assist

Chronic myeloid leukemia

Chronic myeloid leukaemia (CML) is the most common myeloproliferative disorder accounting for 15-20% of all leukaemia cases.

Proteinuria

Increased levels of protein in the urine.

Total: 7

(per page)

PMID (PMCID)
30845905	OTHER
	Dasatinib-induced nephrotic syndrome in a patient with chronic myelogenous leukemia: a case report.
	Ochiai S, Sato Y, Minakawa A, Fukuda A, Fujimoto S. BMC Nephrol. 2019;20(1):87.
	A 40-year-old man with chronic myeloid leukemia was referred to our hospital because of proteinuria 18201month after dasatinib therapy was introduced.
10925558	FEMALE
	Nephrotic syndrome in a bone marrow transplant recipient without chronic graft-versus-host disease.
	Chien YH, Lin KH, Lee TY, Lu MY, Tsau YK. J Formos Med Assoc. 2000;99(6):503-6.
	A 5-year-old girl developed severe proteinuria and microscopic hematuria 17 months after allogeneic bone marrow transplantation (BMT) for chronic myeloid leukemia.
9806652	MIXED_SAMPLE	Adult
	Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy.
	Shah M, Jenis EH, Mookerjee BK, Schriber JR, Baer MR, Herzig GP, Wetzler M. Cancer. 1998;83(9):1938-46.
	The authors describe two patients with chronic myeloid leukemia treated with IFN-alpha following high dose chemotherapy who developed renal failure and proteinuria after 3 and 4 weeks of IFN-alpha therapy, respectively.
9806652	MIXED_SAMPLE	Adult
	Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy.
	Shah M, Jenis EH, Mookerjee BK, Schriber JR, Baer MR, Herzig GP, Wetzler M. Cancer. 1998;83(9):1938-46.
	Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy.
1442766	MALE	Middle Aged
	Unusual glomerular lesion in a patient receiving long-term interferon alpha.
	Lederer E, Truong L. Am J Kidney Dis. 1992;20(5):516-8.
	A 60-year-old man with long-standing chronic myelogenous leukemia presented with renal insufficiency and proteinuria after more than 6 years of therapy with daily interferon alpha injections.
1893353	MALE	Adult
	Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia.
	Schilling PJ, Kurzrock R, Kantarjian H, Gutterman JU, Talpaz M. Cancer. 1991;68(7):1536-7.
	A 19-year-old man with Philadelphia-positive chronic myelogenous leukemia treated with interferon-alpha (IFN-alpha) therapy for 45 months had systemic lupus erythematosus disease features: malar rash, migratory arthralgias, elevated antinuclear antibodies, elevated antinative DNA, hypocomplementemia, lymphopenia, and proteinuria.
2529382	FEMALE
	[A case of chronic myelogenous leukemia complicated with nephrotic syndrome].
	Yoshizaki N, Kohda K, Nakazawa O, Ando M, Miyazaki S, Takahashi M, Muramatsu H, Terada S, Kure T, Niitsu Y. Rinsho Ketsueki. 1989;30(5):691-6.
	On admission, proteinuria (21.5 g/dl) and hypoalbuminemia (2.5 g/day) were pointed out, and the renal biopsy specimen showed membraneous proliferative glomerulonephritis (MPGN), so we diagnosed this case that chronic myelogenous leukemia (CML) complicated with nephrotic syndrome.